Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03424603
Title Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sutro Biopharma, Inc.

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

mantle cell lymphoma

multiple myeloma

B-cell lymphoma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.